CAS: 1196109-52-0 - N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide
Fórmula:C24H23F3N4O2
InChI:InChI=1S/C24H23F3N4O2/c25-24(26,27)19-6-7-22(29-15-19)33-21-5-1-3-18(14-21)13-17-8-11-31(12-9-17)23(32)30-20-4-2-10-28-16-20/h1-7,10,14-17H,8-9,11-13H2,(H,30,32)
Clave InChI:InChIKey=NBOJHRYUGLRASX-UHFFFAOYSA-N
SMILES:O=C(NC=1C=NC=CC1)N2CCC(CC=3C=CC=C(OC4=NC=C(C=C4)C(F)(F)F)C3)CC2
- Sinónimos:
- 1-Piperidinecarboxamide, N-3-pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-
- Pf-3845
Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
---|---|---|---|---|
PF 3845 hydrate REF: 7W-GK5770CAS: 1196109-52-0 | - - - | A consultar | Mar 10 Dic 24 | |
PF-3845 REF: TM-T6043CAS: 1196109-52-0 | 99.54% - 99.58% | 41,00 €~554,00 € | Jue 12 Dic 24 | |
PF 3845 REF: TR-P293760CAS: 1196109-52-0 | - - - | 185,00 €~1.207,00 € | Mié 15 Ene 25 | |
PF 3845 REF: 3D-FP102746CAS: 1196109-52-0 | Min. 95% | A consultar | Jue 16 Ene 25 | |
N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide REF: IN-DA008SSACAS: 1196109-52-0 | 98% | - - - | Producto descatalogado |
Ref: 7W-GK5770
Tamaño no definido | A consultar |
PF-3845
- Amidas
- Inhibidores
- Inmunología e inflamación
- Metabolismo
- Ver más categorías
- FAAH
- Autofagia
Ref: TM-T6043
2mg | 41,00 € | ||
5mg | 59,00 € | ||
10mg | 96,00 € | ||
25mg | 203,00 € | ||
50mg | 380,00 € | ||
100mg | 554,00 € | ||
1mL*10mM (DMSO) | 59,00 € |
PF 3845
Producto controladoRef: TR-P293760
10mg | 185,00 € | ||
50mg | 707,00 € | ||
100mg | 1.207,00 € |
PF 3845
Ref: 3D-FP102746
1g | 1.739,00 € | ||
50mg | 436,00 € | ||
100mg | 647,00 € | ||
250mg | 924,00 € | ||
500mg | 1.160,00 € |
N-3-Pyridinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methyl]-1-piperidinecarboxamide
Ref: IN-DA008SSA
1g | Descatalogado | Solicitar información | |
50mg | Descatalogado | Solicitar información | |
100mg | Descatalogado | Solicitar información | |
250mg | Descatalogado | Solicitar información |